Infliximab-dyyb

Next

Zymfentra® ,

Infliximab-dyyb

Disease
Crohn's disease , Ulcerative colitis ,
Drug Class
Biologics/Biosimilars
Delivery Method
Injection or
Brand name:
Zymfentra® ,
Drug name:
Infliximab-dyyb
Drug type
Anti-TNF
Recommendations for pregnancy

Low risk

Recommendations for breastfeeding

Limited human data, probably compatible

Most common side effects

Common side effects include:

For ulcerative colitis: COVID-19, anemia, arthralgia, injection site reaction, increased alanine aminotransferase, and abdominal pain

For Crohn's disease: COVID-19, headache, upper respiratory tract infection, injection site reaction, diarrhea, increased blood creatine phosphokinase, arthralgia, increased alanine aminotransferase, hypertension, urinary tract infection, neutropenia, dizziness and leukopenia 

 

Other

Serious infections have included tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body or cause infections in certain areas. Lymphoma, including hepatosplenic T-cell lymphoma, and other cancers, have also been reported. 

 

 

 

Learn more about Biologics/Biosimilars
Link
View other biologics
Web Address
Fact Sheet
Biologics fact sheet
PDF
Brochure
Understanding IBD Medications brochure
PDF

Biologics for IBD

Video Length 00:01:21

Biologics for IBD Biologics are antibodies grown in the laboratory that stop specific proteins in the body from causing inflammation. Their mechanisms of action are more precisely targeted to the factors responsible for IBD.